https://mbf.kriskon.ru/naukadocs/ 2025-10-02T15:30:41+00:00 https://mbf.kriskon.ru/naukadocs/safety-and-tolerability-of-dim-based-therapy-designed-as-personalized-approach-to-reverse-prostatic-intraepithelial-neoplasia-pin/ 2025-04-07T14:32:10+00:00 https://mbf.kriskon.ru/naukadocs/preclinical-antitumor-activity-of-the-diindolylmethane-formulation-in-xenograft-mouse-model-of-prostate-cancer/ 2025-04-07T14:32:48+00:00 https://mbf.kriskon.ru/naukadocs/issledovanie-farmakokinetiki-novoj-formulyatsii-diindolilmetana-na-patsientkah-s-giperplaziej-endometriya/ 2025-04-07T14:33:14+00:00 https://mbf.kriskon.ru/naukadocs/otsenka-perenosimosti-i-bezopasnosti-novoj-formulyatsii-diindolilmetana-u-patsientok-s-giperplaziej-endometriya/ 2025-04-07T14:33:21+00:00 https://mbf.kriskon.ru/naukadocs/promezhutochnye-rezultaty-issledovaniya-bezopasnosti-i-perenosimosti-farmatsevticheskoj-kompozitsii-na-osnove-diindolilmetana-u-patsientok-s-giperplaziej-endometriya-bez-atipii/ 2025-04-07T14:33:27+00:00 https://mbf.kriskon.ru/naukadocs/comparative-preclinical-pharmacokinetics-study-of-3-3-diindolylmethane-formulations-is-personalized-treatment-and-targeted-chemoprevention-in-the-horizon/ 2025-04-18T11:46:42+00:00 https://mbf.kriskon.ru/naukadocs/3-3-diindolylmethane-improves-the-viral-pneumonia-outcomes-after-influenza-and-sars-cov-2-infection-in-animal-models/ 2025-10-02T15:30:41+00:00